A novel nucleolin-binding peptide for Cancer Theranostics
Jae Hyun Kim, Chanhyung Bae, Minjung Kim, In-Hye Song, Jae‐Ha Ryu, Jang-Hyun Choi, Choong-Jae Lee, Jeong‐Seok Nam, Jae Il Kim
Abstract
In summary, our findings indicated that NCL-targeting AGM-330 has great potential for use in cancer diagnosis and targeted drug delivery in cancer therapy.
Topics & Concepts
NucleolinCancer cellIn vivoIn vitroChemistryPeptideCancer researchFlow cytometryCancerImmunogenicityMolecular biologyAntigenBiochemistryBiologyImmunologyNucleolusBiotechnologyCytoplasmGeneticsAdvanced biosensing and bioanalysis techniquesRNA and protein synthesis mechanismsRNA Interference and Gene Delivery